Cevian holds 9.6% of Smith & Nephew (NYSE: SNN) shares
Rhea-AI Filing Summary
Cevian Capital II GP LTD filed Amendment No. 4 to its Schedule 13D on Smith & Nephew plc, reporting beneficial ownership of 81,687,136 ordinary shares, equal to 9.6% of the outstanding shares. Cevian has sole voting and dispositive power over this entire stake.
Cevian states it bought these shares for the Cevian funds for total consideration of about USD $1,095,708,998, funding the purchases from the funds’ general working capital and paying in British pounds, using an exchange rate of USD $1.32385 per GBP 1.00. The 9.6% figure is based on 849,889,305 ordinary shares outstanding as of February 28, 2026, as reported by the issuer on Form 6-K filed on March 2, 2026.
Positive
- None.
Negative
- None.
Insights
Cevian discloses a sizable 9.6% stake in Smith & Nephew.
Cevian Capital II GP LTD reports beneficial ownership of 81,687,136 Smith & Nephew ordinary shares, representing 9.6% of the company. All of these shares are under Cevian’s sole voting and dispositive control, indicating a consolidated position rather than fragmented holdings.
The filing shows that Cevian funds spent roughly USD $1,095,708,998 to build the stake, funded from their general working capital and executed in British pounds at USD $1.32385 per GBP. The ownership percentage is calculated against 849,889,305 shares outstanding as of February 28, 2026, tying the stake directly to the company’s reported share count.
This amendment primarily updates ownership and funding details and references recent trading activity in Schedule B. It does not itself specify strategic intentions, so any implications for Smith & Nephew will depend on future disclosures or actions associated with this 9.6% holding.